A Netflix-type model could lower the cost of one-time gene therapy treatments, said Jane Barlow, the chief clinical officer for Real Endpoints, a data analytics company for the healthcare industry.

Why it matters: Current medicines spread their costs out over time. Gene therapy treatments are likely to cost the health care system billions of dollars, and drugmakers are already having to come up with creative ways to get paid for high-cost drugs, Axios' Caitlin Owens reports.

Go deeper

Updated Aug 4, 2020 - Axios Events

Watch: How hospitals have responded to the pandemic

On Tuesday, August 4 Axios health care reporter Caitlin Owens hosted a virtual event on how hospitals have been responding to the coronavirus pandemic, from getting PPE to building the future of resilient health systems, featuring Atrium Health CEO Eugene Woods, K Health co-founder & CEO Allon Bloch and Columbia University Medical Center professor and FemInEm founder Dr. Dara Kass.

Allon Bloch argued that a rise in the usage of telemedicine presents an opportunity for people to reimagine how the U.S. health care system can be more efficient and cost-effective.

  • On integrating more data analysis into medicine: "There's a massive opportunity to give people a much more nuanced approach to medicine, a much more personalized one, based on information [from] their own personal history or from similar situations...It's a little bit overlooked in medicine."
  • On how telemedicine can positively impact the health care system: "There's a lot of people that are either not insured or underinsured. They have really high deductibles. They can't afford doctors...[telemedicine] can give people access to really high quality primary care at a much lower cost."

Eugene Woods discussed his company's "virtual hospitals" and how this model has the potential to reduce overflow into physical hospitals.

  • On his company's "virtual hospital" treating COVID-19 patients: "We've treated about 13,000 patients in our virtual hospital and only three percent have had to be transferred or admitted from the virtual hospital into [a physical] hospital."
  • On reducing disparities in COVID-19 testing: "[Coronavirus] has laid bare the racial disparities that have existed in these communities for decades...Back in March, we realized there were disparities in terms of testing. So we have roving medical vans and went into those [affected] communities. We so far have hit about 55 different community host sites."

Dr. Dara Kass unpacked her experience of working in the ICUs in New York City during the initial COVID-19 outbreak, and how safety measures like masks and social distancing impacted the rate and spread of the virus.

  • How wearing masks reduces the volume of COVID-19 patients coming to the ICU: "We saw the effects of our work of social distancing and wearing masks as early as April take effect pretty dramatically...We also saw the peak come down as almost as quickly as it went up."
  • How this crisis compounds existing gender inequities: "Our child care crisis was bad before, pay inequity was bad before — it's exacerbated by this at this moment. We're worried about frontline healthcare workers now, not even being able to go back to work because of the fact that child care will be inaccessible and schools are probably not going to open."

Thank you Philips for sponsoring this event.

Senate advances Amy Coney Barrett nomination, setting up final confirmation vote

Photo: Xinhua/Ting Shen via Getty Images

The Senate voted 51-48 on Sunday to advance the Supreme Court nomination of Judge Amy Coney Barrett, setting up a final confirmation vote for Monday.

Why it matters: It's now virtually inevitable that the Senate will vote to confirm President Trump's third Supreme Court nominee before the election, which is just nine days away.

Felix Salmon, author of Capital
2 hours ago - Economy & Business

Wall Street is living up to its bad reputation

Illustration: Sarah Grillo/Axios

Recent headlines will have you convinced that Wall Street is hell-bent on living up to all of its stereotypes.

Driving the news: Goldman Sachs is the biggest and the boldest, paying more than $5 billion in fines in the wake of the 1MDB scandal, in which billions were stolen from the people of Malaysia.